Used primarily in biochemical research, this compound is a potent and selective degrader of target proteins through the proteolysis-targeting chimera (PROTAC) technology. It is widely applied in studying protein function and regulation, particularly in cancer research, where it helps in understanding the degradation of oncogenic proteins. Additionally, it is utilized in drug discovery to develop novel therapeutic strategies by selectively eliminating disease-causing proteins. Its application extends to neurodegenerative disease studies, where it aids in exploring protein aggregation and degradation pathways.